top of page
News
Search


Bringing Specialized Cancer Care Closer to Home: Research Supports Expanding Access to CRS/HIPEC
Accessing specialized treatment for advanced abdominal cancers can require significant travel. A Canadian study identified 31 patients in one year who met eligibility criteria for CRS/HIPEC, supporting the potential development of a local treatment program. The findings highlight the importance of expanding access to specialized cancer care while maintaining the expertise, multidisciplinary collaboration, and resources necessary for safe, effective treatment.
Abdominal Cancers Alliance
Nov 10


Timing Matters: Does Waiting Longer for Stomach Cancer Surgery Affect Outcomes?
Does waiting longer for stomach cancer surgery after chemotherapy affect survival? A new study of 122 patients found no significant differences in survival, cancer recurrence, or serious surgical complications based on the time between chemotherapy and surgery. The findings suggest that some flexibility in surgical timing may be appropriate, allowing patients time to recover and prepare for surgery while receiving coordinated, individualized cancer.
Abdominal Cancers Alliance
Nov 4


Mental Health Matters: Depression and Anxiety Linked to Recovery After Gastric Cancer Surgery
A new study of 1,502 patients undergoing gastrectomy for gastric cancer found that those with documented depression or anxiety had longer hospital stays, higher postoperative complication rates, and greater healthcare costs than patients without these diagnoses. The findings suggest mental health screening and supportive care may be an important part of preparing for major cancer surgery, while emphasizing that depression or anxiety should not limit access to potentially cura
Abdominal Cancers Alliance
Oct 7


Targeting Peritoneal Metastases from Two Directions: The Promise of NIPS
A new review explores NIPS, an approach that combines chemotherapy delivered directly into the abdominal cavity with systemic treatment for gastrointestinal cancers that have spread to the peritoneum. Paclitaxel-based NIPS has shown the most encouraging results in gastric cancer, with some patients responding enough to become surgical candidates. Research in colorectal and pancreatic cancers is still early, and more studies are needed.
Abdominal Cancers Alliance
Oct 6


Molecular Testing May Offer a New Way to Improve Staging of Gastric Cancer
New research from MD Anderson explores whether next-generation sequencing (NGS) of fluid collected during peritoneal washing could help improve staging for gastric cancer. By looking for tumor-derived genetic material in the washing fluid, researchers are investigating a potential way to identify microscopic peritoneal spread that may be difficult to detect with imaging or cytology alone. The approach remains investigational but could eventually support more precise treatment
Abdominal Cancers Alliance
Sep 30


Seeing What CT Scans Can Miss: Improving Peritoneal Cancer Staging Before Surgery
A new study found that while CT scans provide a useful estimate of the extent of peritoneal metastases, they often underestimate the amount of cancer found during surgery. Diagnostic laparoscopy may offer a more accurate assessment in selected patients, helping physicians make more informed decisions about cytoreductive surgery.
Abdominal Cancers Alliance
Aug 11


Does Chemotherapy Before Surgery Increase Surgical Risks for Stomach Cancer?
If your care team recommends chemotherapy before stomach cancer surgery, you may wonder whether it makes surgery riskier. This study found that patients who received chemotherapy before surgery had similar complication rates, hospital stays, and survival as those who had surgery first—and were even less likely to be readmitted to the hospital after surgery.
Abdominal Cancers Alliance
Jul 22


Could Repeated Intraperitoneal Chemotherapy Improve Treatment for Peritoneal Metastases?
Peritoneal metastases are difficult to treat because standard IV chemotherapy often cannot reach tumors inside the abdomen effectively. This review explores NIPS, an approach that combines intravenous chemotherapy with repeated chemotherapy delivered directly into the abdominal cavity. Early research—especially in gastric cancer—suggests this strategy may improve disease control, increase eligibility for surgery, and help some patients live longer.
Abdominal Cancers Alliance
Jul 7


New Study Sheds Light on Peritoneal Metastases Across Multiple Cancer Types
Researchers found that blue LED light reduced the growth and spread of gastric cancer peritoneal metastases in a mouse model, highlighting a potential new treatment approach that warrants further study.
Abdominal Cancers Alliance
Jun 12


New Treatment Strategy for Gastric Cancer That Has Spread to the Peritoneum
Associations between the primary colorectal tumor budding score and the histological growth pattern of peritoneal metastases: A pilot study . Bouatrous, Mendhi et al. Surgical Oncology Insight, Volume 3, Issue 1, 100236 . About This Research Gastric (stomach) cancer that spreads to the lining of the abdomen—called peritoneal carcinomatosis—is one of the most difficult forms of the disease to treat. Traditional chemotherapy given through the bloodstream often struggles to re
Abdominal Cancers Alliance
Mar 16


The Importance of Staging Laparoscopy Before Treatment for Gastric Cancer
Ostowari A, Chen KT, Hasjim BJ, Montero S, Sedighim S, Tajik F, Roman M, Dayyani F, Daly S, Smith BR, Nguyen NT, Eng OS, O'Leary MP, Senthil M. Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer. Ann Surg Oncol. 2026 Feb;33(2):1343-1349. doi: 10.1245/s10434-025-18547-4. Epub 2025 Oct 17. PMID: 41107646; PMCID: PMC12765731. When stomach (gastric) cancer or gastroesophageal junction (GEJ) cancer is diagnosed, doctors often recommend
Abdominal Cancers Alliance
Feb 20


How Abdominal Chemotherapy May Help the Immune System Fight Stomach Cancer
Matsumiya, M., Sonoda, H., Yamashita, H. et al. Intraperitoneal Paclitaxel-Induced Eosinophil Recruitment as a Potential Mediator of Tumor Response in Peritoneal Metastases from Gastric Cancer. Ann Surg Oncol (2026). https://doi.org/10.1245/s10434-025-19075-x What was studied? Researchers looked at how i ntraperitoneal chemotherapy (medicine delivered directly into the abdominal cavity) affects the immune environment in people with gastric (stomach) cancer that has spread t
Abdominal Cancers Alliance
Feb 12


Exploring New Frontiers in Cancer Treatment: The STOPGAP Trial
Phase II trial of systemic therapy plus intraperitoneal (IP) paclitaxel (PTX) in gastric/GEJ cancer peritoneal carcinomatosis (GPC): STOPGAP trial.
Abdominal Cancers Alliance
Jan 21


Gastric and Pancreatic Cancers Awareness Month 2025 - In Case You Missed It
During November we recognized Gastric and Pancreatic Cancer Awareness Month to bring more attention to advanced forms of this cancer. In case you missed it, here's a quick recap for the month! Understanding Gastric Cancer: Risks, Outlook, and Advances Gastric cancer, also known as stomach cancer, is a rare and aggressive cancer that develops in the stomach, which is responsible for breaking down food during digestion. Most (90-95%) gastric cancers begin in the stomach’s inne
Abdominal Cancers Alliance
Nov 24, 2025
Join us! Support our work today!
Donate
X
Do you have any suggestions for us? Your feedback is very valuable!
bottom of page
